Clinical Trials Logo

Acute Antibody-Mediated Rejection (AMR) clinical trials

View clinical trials related to Acute Antibody-Mediated Rejection (AMR).

Filter by:
  • None
  • Page 1

NCT ID: NCT02547220 Terminated - Clinical trials for Acute Antibody-Mediated Rejection (AMR)

A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant

Start date: May 20, 2016
Phase: Phase 3
Study type: Interventional

The main purpose of the study is to evaluate the efficacy of CINRYZE administered with plasmapheresis, plasma exchange, or immune adsorption treatments and sucrose-free immunoglobulin (IVIg) for the treatment of acute antibody-mediated rejection (AMR) of renal allograft in kidney transplant recipients as measured by the proportion of participants with new or worsening transplant glomerulopathy (TG) at 6 months after treatment initiation.